ARTICLE | Clinical News
Luveniq voclosporin regulatory update
March 8, 2010 8:00 AM UTC
The European Medicines Agency (EMA) accepted for filing an MAA from Lux Biosciences for Luveniq voclosporin to treat non-infectious uveitis involving the intermediate or posterior segments of the eye....